Aneuro is a brand of ACROBiosystems dedicated to advancing neuroscience research and delivering innovative solutions. Aneuro aims to contribute to the understanding and treatment of neurological ...

Over the past few years, AbbVie’s ABBV neuroscience franchise has shifted from a secondary portfolio to a meaningful growth ...

AbbVie ABBV has built a robust neuroscience franchise over the years. Though the segment was initially heralded by blockbuster medications like Botox Therapeutic and the depression drug Vraylar, the ...

Alkermes has a portfolio of commercialized neuroscience products and a pipeline that spans both neuroscience and cancer. The drugmaker is now exploring the possibility of splitting off its cancer ...

Long-term investors shouldn't overlook this top pharma stock and top medical device maker. AbbVie is seeing impressive growth from both its immunology portfolio and neuroscience products. Medtronic is ...

AbbVie Inc. reported strong Q4 2024 results, driven by Skyrizi, Rinvoq, neuroscience products, and eye care, and this offset worse-than-expected Humira erosion. 2025 guidance includes $59 billion in ...

Marine organisms produce a wide variety of primary and secondary metabolites with unique scaffolds that are biologically active. Manzamines are marine-derived polycyclic alkaloids. Approximately 100 ...

Medtronic said steady demand for its cardiovascular and neuroscience products boosted revenue in its fiscal third quarter, though the top line was below analyst forecasts. The medical-technology ...